APA (7th ed.) Citation

EW, C., JY, H., SC, L., CN, H., YS, Y., & E, K. (2025). Association between SGLT-2 inhibitors and suicide risk in type 2 diabetes and bipolar: A real-world cohort study. Frontiers in pharmacology, 16, 1601118. https://doi.org/10.3389/fphar.2025.1601118

Chicago Style (17th ed.) Citation

EW, Chang, Huang JY, Lo SC, Huang CN, Yang YS, and Kornelius E. "Association Between SGLT-2 Inhibitors and Suicide Risk in Type 2 Diabetes and Bipolar: A Real-world Cohort Study." Frontiers in Pharmacology 16 (2025): 1601118. https://doi.org/10.3389/fphar.2025.1601118.

MLA (9th ed.) Citation

EW, Chang, et al. "Association Between SGLT-2 Inhibitors and Suicide Risk in Type 2 Diabetes and Bipolar: A Real-world Cohort Study." Frontiers in Pharmacology, vol. 16, 2025, p. 1601118, https://doi.org/10.3389/fphar.2025.1601118.